Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.

作者: Marnett Lj , Martin Mv , Shimada T , Guengerich Fp , Pruess-Schwartz D

DOI:

关键词: Cytochrome P450EnzymeIsozymeBiochemistryChemistryPyreneFluorantheneMicrosomeCarcinogenBenzo(a)pyrene

摘要: Human liver microsomes oxidized 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene [B(a)P-7,8-diol] to products that yield DNA adduct formation and umu gene expression in the tester system Salmonella typhimurium TA1535/pSK1002. The response is correlated levels of microsomal cytochrome P-450NF (P-450NF) nifedipine oxidation different human samples used for activation, both (+)- (-)-enantiomers B(a)P-7,8-diol gave similar results these other assays. was inhibited by antibodies raised against P-450NF. 7,8-Benzoflavone stimulated B(a)P-7,8-diol-dependent observed with purified lung microsomes. Thus, appears be major enzyme involved activation possibly lung. Similar were obtained trans-9,10-dihydroxy-9,10-dihydrobenzo(b)fluoranthene trans-3,4-dihydroxy-3,4-dihydro-7,12-dimethylbenz(a)anthracene, compounds are known form highly tumorigenic diol-epoxides. product (+)-B(a)P-7,8-diol cis-syn isomer benzo(a)pyrene-7,8,9,10-tetraol[7 beta, 8 alpha, 9 10 beta-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene]. Studies on nature enzymes [from benzo(a)pyrene] indicate neither P-450NF, P-450PA, P-450j, P-450DB, nor P-450MP involved. correlation 7,8-diol phenacetin O-deethylation a set partial inhibition reaction 7,8-benzoflavone anti-rat P-450 beta NF-B suggest may P1-450, ortholog rat NF-B, which catalyzes its subsequent tissues polycyclic hydrocarbon-treated rats. differential effects inhibitors benzo(a)pyrene 3-hydroxylation, 4,5-epoxidation, 9,10-epoxidation catalyzed an enzyme(s) distinct from forms 7,8-epoxide. roles differ rodent orthologs paradigm bioactivation hydrocarbons; further, flavones appear have opposing diol further epoxidation

参考文章(49)
F. P. Guengerich, Cytochrome P-450 enzymes and drug metabolism Progress in drug metabolism. ,vol. 10, pp. 1- 54 ,(1987)
William D. Parsons, Allen H. Neims, Effect of smoking on caffeine clearance Clinical Pharmacology & Therapeutics. ,vol. 24, pp. 40- 45 ,(1978) , 10.1002/CPT197824140
P. Leber, P.W. Jones, Polynuclear aromatic hydrocarbons Ann Arbor Science Publishers Inc.,Ann Arbor, MI. ,(1979)
Laurence S. Kaminsky, Michael J. Fasco, F. Peter Guengerich, [16] Production and application of antibodies to rat liver cytochrome P-450 Methods in Enzymology. ,vol. 74, pp. 262- 272 ,(1981) , 10.1016/0076-6879(81)74018-7
Mehdi Boroujerd, Marshall W. Anderson, Alan G. E. Wilson, Hsiao-Chia Kung, Inhibition in Vivo of the Formation of Adducts between Metabolites of Benzo(a)pyrene and DNA by Aryl Hydrocarbon Hydroxylase Inducers Cancer Research. ,vol. 41, pp. 3453- 3460 ,(1981)
C. Szumlanski, R. Weinshilboum, T. Wilke, W. Rhodes, R. Nelson, I. Jardine, R. Van Dyke, L. Benson, G. Powis, D. Moore, Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage. Drug Metabolism and Disposition. ,vol. 16, pp. 582- 589 ,(1988)
F P Guengerich, M V Martin, P H Beaune, P Kremers, T Wolff, D J Waxman, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry. ,vol. 261, pp. 5051- 5060 ,(1986) , 10.1016/S0021-9258(19)89213-X